Last viewed:
apdn
Prices are updated after-hours
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
(0.0% 1d)
(-31.1% 1m)
(-66.9% 1y)
(0.0% 2d)
(0.0% 3d)
(-4.4% 7d)
(43.62%
volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 5,765,968
http://www.adnas.com
Sec
Filling
|
Patents
| 51 employees
(US) Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
security
brands
add to watch list
Paper trade
email alert is off
Press-releases
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
Published: 2024-03-18
(Crawled : 13:30)
- biospace.com/
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -6.44%
| O: 1.28%
H: 21.2%
C: 18.06%
start
dna
agreement
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Published: 2024-02-08
(Crawled : 00:00)
- biospace.com/
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -42.62%
| O: 5.0%
H: 0.02%
C: -4.76%
first
year
dna
financial
results
Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
Published: 2024-02-05
(Crawled : 23:00)
- biospace.com/
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -40.04%
| O: 0.14%
H: 4.33%
C: -2.19%
first
report
dna
financial
results
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: 2024-01-31
(Crawled : 15:30)
- biospace.com/
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -42.62%
| O: -5.0%
H: 8.6%
C: 1.32%
nasdaq
million
direct
offering
dna
Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
Published: 2023-12-07
(Crawled : 00:00)
- biospace.com/
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -68.98%
| O: -6.31%
H: 9.62%
C: 3.85%
year
dna
financial
results
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
Published: 2023-12-05
(Crawled : 16:00)
- biospace.com/
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -65.22%
| O: 2.02%
H: 7.92%
C: 2.17%
report
year
dna
financial
results
Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
Published: 2023-11-28
(Crawled : 15:00)
- biospace.com/
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -60.88%
| O: 2.27%
H: 4.81%
C: -0.22%
diagnostic
cancer
dna
order
application
Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
Published: 2023-11-16
(Crawled : 14:30)
- biospace.com/
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -56.96%
| O: 6.25%
H: 0.0%
C: -0.94%
dna
application
platform
APDN Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
Published: 2023-09-06
(Crawled : 14:00)
- adnas.com
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
| -47.03%
| O: 4.38%
H: 2.21%
C: -3.03%
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -73.31%
| O: -1.55%
H: 2.36%
C: 0.0%
Applied DNA Announces Availability and First Customer Shipment of New Linea™ IVT Evaluation Kit
Published: 2023-08-29
(Crawled : 20:00)
- adnas.com
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
| -72.89%
| O: 7.09%
H: 0.0%
C: -7.35%
dna
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount